Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contrast-Enhanced Ultrasound Evaluation of Radioembolization Treatment Response

NCT07145801 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT07145801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07145801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contrast-Enhanced Ultrasound Evaluation of Radioembolization Treatment Response
Lead sponsor
Thomas Jefferson University
Phase
Phase 2
Overall status
Recruiting
Start date
September 11, 2025
Completion date
June 30, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hcc, hepatic neoplasm, hepatocellular carcinoma, liver cancer, liver neoplasm, primary liver cancer